Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context (Q58864342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

16 February 2020

main subject

1 reference

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Hillegonda Novaes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Marcos Amaku

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

Ricardo Arraes de Alencar Ximenes

16 February 2020

8

object named as

Ricardo Arraes de Alencar Ximenes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

Celina Maria Turchi Martelli

16 February 2020

9

object named as

Celina Maria Turchi Martelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Patrícia Coelho de Soárez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Raymundo Soares de Azevedo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Regina Célia Moreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Leila Maria Moreira Beltrão Pereira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

27 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

7489-7497

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Incidence of hepatitis A in Israel following universal immunization of toddlers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Incidence of Hepatitis A in Argentina after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Vaccination against rubella: analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Hepatitis A as an etiologic agent of acute liver failure in Latin America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

An economic analysis of different strategies of immunization against hepatitis A virus in developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

The cost of hepatitis A infections in American adolescents and adults in 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness analysis of routine rotavirus vaccination in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Long-term protective effects of hepatitis A vaccines. A systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Regional variation in the cost effectiveness of childhood hepatitis A immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

The intensity of transmission of hepatitis A and heterogeneities in socio-environmental risk factors in Rio de Janeiro, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.056

10.1016/J.VACCINE.2012.10.056

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107593%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference